@article{acde9e6393344693ae6a32054b1aa846,
title = "Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancer",
abstract = "Cigarette smoking is a major risk factor for bladder cancer (BC); however, the impact of cigarette content remains unclear. This study aims to investigate tar, nicotine and carbon monoxide (TNCO) yields of different filtered cigarettes in relation to BC risk. From the Bladder Cancer Prognosis Programme 575 non-muscle-invasive bladder cancer (NMIBC) cases, 139 muscle-invasive bladder cancer (MIBC) cases and 130 BC-free controls with retrospective data on smoking behaviour and cigarette brand were identified. Independently measured TNCO yields of cigarettes sold in the UK were obtained through the UK Department of Health and merged with the Bladder Cancer Prognosis Programme dataset to estimate the daily intake of TNCO. BC risk increased by TNCO intake category for NMIBC cases (P",
keywords = "epidemiology, smoking, toxicology, urinary bladder neoplasms, TOBACCO SMOKING, SMOKERS, MALES",
author = "{van Osch}, {Frits H. M.} and Pauwels, {Charlotte G. G. M.} and Jochems, {Sylvia H. J.} and Ranti Fayokun and James, {Nicholas D.} and Wallace, {D. Michael A.} and Kar-keung Cheng and Bryan, {Richard T.} and {van Schooten}, {Frederik J.} and Zeegers, {Maurice P.}",
note = "Funding Information: aDepartment of Complex Genetics and Epidemiology, bDepartment of Pharmacology and Toxicology, NUTRIM School for Nutrition and Translational Research in Metabolism, cDepartment of Complex Genetics and Epidemiology, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, dCentre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, eInstitute of Cancer and Genomic Sciences, fDepartment of Public Health and Epidemiology, University of Birmingham, gDepartment of Urology, University Hospital Birmingham, NHS Foundation Trust, Birmingham and hDepartment of Medicine, Centre for Pharmacology and Therapeutics, Division of Experimental Medicine, Imperial College London, London, UK Funding Information: The authors thank all the West Midlands Consultant Urologists and their units involved with BCPP, as well as the BCPP research nurses. The BCPP programme is funded by Cancer Research UK and supported by the Department of Public Health and Epidemiology and the Institute of Cancer of Genomic Sciences, University of Birmingham. Publisher Copyright: {\textcopyright} 2018 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2019",
month = jan,
doi = "10.1097/CEJ.0000000000000404",
language = "English",
volume = "28",
pages = "40--44",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams & Wilkins",
number = "1",
}